Emcure Pharmaceuticals Share Price
Small Cap | Pharmaceuticals and health care | NSE: EMCURE | BSE: 544210
₹1,021.90 
12.80 (1.27 %)
Last Updated: 30 Apr 2025 03:57 PM
BEARISH
Overview
Open (₹) 1,018.90
High (₹) 1,048.50
Low (₹) 1,000.40
Prev. Close (₹) 1,009.10
Volume 52,010
VWAP (₹) 1,075.38
ROCE (%) 21.20
Industry P/E 46.55
TTM P/E 31.87
P/B Ratio 5.93
Market Cap (₹) Cr.19,363.30
Dividend Yield (%)0.29
EPS (₹) 27.54
ROE15.98%
Sales Growth (%) 11.23
Profit Growth (%)-6.10
Day Range
1,048.501,048.50
52 Week Range
890.001,577.50
Historical Returns
Returns (6M)
-29.21 %
Returns (1Y)
-24.81 %
Returns (3Y)
-24.81 %
Returns (5Y)
-24.81 %
Returns (6M)
-29.21 %
Returns (1Y)
-24.81 %
Returns (3Y)
-24.81 %
Returns (5Y)
-24.81 %
SWOT Analysis
Technicals
Technical Rating
BEARISHRSI 45.86
MFI 84.95
ATR 66.54
Commodity Channel Index 96.39
ROC125 -25.15
ROC21 18.44
Williams %R -16.41
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 1,135.76 | 1,172.73 | 1,236.36 | 1,072.13 | 1,035.16 | 971.53 | 934.56 |
| Week Ago | 947.06 | 988.53 | 1,012.06 | 923.53 | 882.06 | 858.53 | 817.06 |
| Month Ago | 939.89 | 954.22 | 968.69 | 925.42 | 911.09 | 896.62 | 882.29 |
EMA & SMA
1021.90
Current Price
Bullish Moving Averages
14
Bearish Moving Averages
4
5 Day 953.06
9 Day 987.53
10 Day 996.83
12 Day 1009.50
14 Day 1007.30
20 Day 995.42
26 Day 985.91
50 Day 1034.48
100 Day 1197.03
200 Day N/A
Deals & Announcements
Bulk and Block Deals
Insider Trading
Corporate Actions
No corporate actions available.
Announcements
| Date | Source | Detail |
|---|---|---|
| 18th Apr, 2025 | BSE India | Announcement under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (\SEBI Listing Regulations\) - Update on USFDA inspection at API manufacturing facility located at Kurkumbh, Pune, Maharashtra, India |
| 18th Apr, 2025 | NSE India | Emcure Pharmaceuticals Limited has informed the Exchange about General Updates |
| 18th Apr, 2025 | NSE India | Emcure Pharmaceuticals Limited has informed the Exchange regarding ''Intimation of change in email and website address of Registrar and Share Transfer Agent of the Company''. |
| 18th Apr, 2025 | BSE India | Intimation of change in email and website address of Registrar and Share Transfer Agent of the Company |
| 8th Apr, 2025 | BSE India | Confirmation Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2025, received from MUFG Intime India Private Limited, the Registrar and Share Transfer Agent (RTA) of the Company. |
| 8th Apr, 2025 | NSE India | Emcure Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
| 4th Apr, 2025 | BSE India | Please find enclosed herewith a Press Release titled \Emcure''s European subsidiary Tillomed acquires strategic pharma portfolio from Manx.\ |
| 4th Apr, 2025 | NSE India | Emcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 04, 2025, titled ""Emcure s European subsidiary Tillomed acquires strategic pharma portfolio from Manx"". |
| 1st Apr, 2025 | BSE India | Please find enclosed herewith a Press Release titled \Emcutix and WiQo Signs Exclusive Licensing Partnership to revolutionize Derma-cosmetic Treatments in India\ by Emcutix Biopharmaceuticals Limited, a subsidiary of Emcure Pharmaceuticals Limited. |
| 1st Apr, 2025 | NSE India | Emcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 01, 2025, titled ""Emcutix and WiQo Sign Exclusive Licensing Partnership to revolutionize Derma-cosmetic Treatments in India"". |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 25th Jan, 2025 | 6th Feb, 2025 |
| Quarterly Results | -- | 29th Oct, 2024 | 7th Nov, 2024 |
| Quarterly Results | -- | 7th Aug, 2024 | 13th Aug, 2024 |
Share Holding Pattern
| Owner Name | Mar, 2025 | Dec, 2024 | |||
|---|---|---|---|---|---|
| Promoter Group | 77.92% | 77.94% | 0% | 0% | 0% |
| Foreign Institutions + | 3.06% | 3.05% | 0% | 0% | 0% |
| Domestic Institutions + | 3.44% | 3.87% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% |
| Public | 15.58% | 15.14% | 0% | 0% | 0% |
| Others | 0% | 0% | 0% | 0% | 0% |
About Emcure Pharmaceuticals
Emcure Pharmaceuticals is a Public Limited Listed company incorporated on 16/04/1981 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24231PN1981PLC024251 and registration number is 024251. Currently Company is involved in the business activities of Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 3497.66 Cr. and Equity Capital is Rs. 181.15 Cr. for the Year ended 31/03/2024.
Parent Organisation
Not Applicable
Founded
1981
Managing Director
Mr. Satish Ramanlal Mehta
NSE Symbol
EMCURE
Emcure Pharmaceuticals Management
| Name | Designation |
|---|---|
| Mr. Berjis Minoo Desai | Chairman & Non-Exe.Director |
| Mr. Satish Ramanlal Mehta | Managing Director & CEO |
| Mr. Sunil Rajanikant Mehta | Whole Time Director |
| Ms. Namita Vikas Thapar | Whole Time Director |
| Mr. Samit Satish Mehta | Whole Time Director |
| Mr. Mukund Keshao Gurjar | Whole Time Director |
| Mr. Samonnoi Banerjee | Non Exe. & Nominee Director |
| Mr. Palamadai Sundararajan Jayakumar | Independent Director |
| Mr. Vijay Keshav Gokhale | Independent Director |
| Ms. Vidya Rajiv Yeravdekar | Independent Director |
| Mr. Shailesh Kripalu Ayyangar | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Sun Pharmaceutical Industries | ₹4,39,630.15 | ₹1,832.30  ₹1,805.50(1.48%) | ₹1,376.750 - ₹1,960.200 |
| Divi's Laboratories | ₹1,61,590.72 | ₹6,087.00  ₹6,108.00(-0.34%) | ₹3,725.550 - ₹6,448.750 |
| Cipla | ₹1,25,192.34 | ₹1,550.10 ₹1,541.50(0.56%) | ₹1,310.050 - ₹1,702.000 |
| Torrent Pharmaceuticals | ₹1,12,431.58 | ₹3,322.00 ₹3,322.70(-0.02%) | ₹2,513.050 - ₹3,589.950 |
| Mankind Pharma | ₹1,01,712.98 | ₹2,465.30 ₹2,556.90(-3.58%) | ₹1,910.100 - ₹3,050.000 |
FAQs on Emcure Pharmaceuticals
What is the share price of Emcure Pharmaceuticals?
The share price of Emcure Pharmaceuticals on 30th Apr, 2025 is ₹ 1,021.90.
What is 52W high and 52W low share price of Emcure Pharmaceuticals?
The highest and lowest 52W share prices of Emcure Pharmaceuticals are ₹ 1577.500 and ₹ 890.000
What is the market cap of Emcure Pharmaceuticals?
The market capitalization of Emcure Pharmaceuticals as of 30th Apr, 2025 is ₹ 19,363.30 Crores
What is the P/E ratio of Emcure Pharmaceuticals?
The current P/E ratio of Emcure Pharmaceuticals as of 30th Apr, 2025 is 46.55
What is the PB ratio of Emcure Pharmaceuticals?
The PB ratio of Emcure Pharmaceuticals as of 30th Apr, 2025 is 5.93
Top Gainers
₹78.00
₹65.00 (0.20%)
₹121.03
₹100.86 (0.20%)
₹13.15
₹11.00 (0.20%)
₹1.88
₹1.57 (0.20%)
Top Losers
₹107.95
₹123.00 (-0.12%)
₹0.50
₹0.56 (-0.11%)
₹24.55
₹28.11 (-0.13%)
₹3.34
₹3.80 (-0.12%)
Market Indices
Sensex
₹80,242.24
₹80,288.38 (0.00%)